ANDA 75548, held by Dr Reddys Labs SA. Ethinyl Estradiol; Norethindrone Acetate.
As of Nov 16, 2026, ANDA 75548 (Microgestin Fe 1.5/30, Microgestin 1.5/30), held by Dr Reddys Labs SA, was first approved by FDA on Feb 5, 2001, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 5, 2001 | Original application | Approved |
| Microgestin Fe 1.5/300.03MG;1.5MG · tablet;oral-28 | Ethinyl Estradiol; Norethindrone Acetate | Discontinued |
| Microgestin 1.5/300.03MG;1.5MG · tablet;oral-21 | Ethinyl Estradiol; Norethindrone Acetate | Discontinued |
| Aug 31, 2021 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jul 30, 2003 | Supplement 4Labeling | Approved | None posted |
| Nov 7, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Jul 23, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Oct 24, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Feb 5, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters